This research study extensively utilized secondary sources, directories, and databases to discover and gather relevant information for the examination of the worldwide pharmaceutical contract manufacturing. Extensive interviews were carried out with primary respondents, such as key industry participants, subject-matter experts (SMEs), C-level executives of major market players, and industry consultants. The purpose was to gather and confirm essential qualitative and quantitative information, as well as evaluate the market's potential for growth. The final market size was determined by triangulating the worldwide market size estimated from secondary research with inputs from primary research.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical contract manufacturing market. The secondary sources used for this study include Indian Pharmaceutical Association (IPA), Pharmaceutical Research and Manufacturers of America (PhRMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Pharma & Biopharma Outsourcing Association (PBOA), Generics and Biosimilars Initiative (GaBI), Pharma Times, Parenteral Drug Association (PDA), Indian Drug Manufacturers’ Association (IDMA), American Association of Pharmaceutical Scientists (AAPS), Global Cancer Observatory, American Chemical Society, National Center for Biotechnology Information, Eurostat, Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), World Journal of Pharmaceutical Sciences, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global pharmaceutical contract manufacturing market scenario through secondary research. Market experts from the demand side—big pharmaceutical companies, small and medium-sized pharmaceutical companies, generic pharmaceutical companies, CROs, C-level and D-level executives, product managers, marketing and sales managers of major manufacturers, distributors, and channel partners—as well as experts from the supply side—C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners. Six main areas—Asia Pacific, North America, Europe, Latin America, Middle East, and Africa—were the sites of these interviews. Approximately 60% and 40% of the primary interviews were conducted with supply-side and demand side participants, respectively. Questionnaires, emails, web surveys, personal interviews, and phone calls gathered this main data.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical contract manufacturing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Bottom-up Approach
-
The key players in the industry and market have been identified through extensive secondary research.
-
The revenues generated from the pharmaceutical contract manufacturing business of leading players have been determined through primary and secondary research to arrive at the overall pharmaceutical contract manufacturing market.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
-
Additionally, to arrive at the pharmaceutical contract manufacturing market for each service, the pharmaceutical contract manufacturing business shares of leading players for each service category were also gathered from secondary sources to the extent available. In some instances, the shares of pharmaceutical contract manufacturing businesses were ascertained through a detailed analysis of various parameters, including service portfolios and market positioning.
-
Individual shares or revenue estimates were validated through expert interviews.
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Pharmaceutical contract manufacturing organizations (CMOs) provide contract-based, comprehensive services, such as drug development and manufacturing. CMOs offer manufacturing services for active pharmaceutical ingredients (APIs) and finished dosage formulations (FDFs). Different aspects of contract manufacturing, such as drug development & manufacturing, formulation development, and commercial pharmaceutical & biopharmaceutical manufacturing, have been considered in this report.
Stakeholders
-
Corporate Entities
-
Venture Capitalists
-
Regulatory Agencies
-
Government Agencies
-
Private Research Firms
-
Academic and Research Institutions
-
Pharmaceutical Distributors and Suppliers
-
Biotechnology and Pharmaceutical Companies
-
Business Research and Consulting Service Providers
-
Contract Research Organizations and Contract Development Manufacturing Organizations
Report Objectives
-
To define, describe, and forecast the global pharmaceutical contract manufacturing market based on the service, end user, and region
-
To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pharmaceutical contract manufacturing market
-
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
-
To profile the key players in the pharmaceutical contract manufacturing market and comprehensively analyze their service portfolios, market positions, and core competencies
-
To track and analyze competitive developments in the pharmaceutical contract manufacturing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
-
To benchmark players within the pharmaceutical contract manufacturing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy
1 Micro markets are the further segments and subsegments of the pharmaceutical contract manufacturing market included in the report
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
-
Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.
Company Information
-
Detailed analysis and profiling of additional market players (up to three).
Geographical Analysis
-
A further breakdown of the Rest of Asia Pacific pharmaceutical contract manufacturing market into countries
-
A further breakdown of the Rest of European pharmaceutical contract manufacturing market into countries
-
A further breakdown of the Rest of Latin American pharmaceutical contract manufacturing market into countries
-
A further breakdown of the Rest of Middle East pharmaceutical contract manufacturing market into countries
Kahlill
Feb, 2023
What will be the key challenges for business in the pharmaceutical contract manufacturing market in the near future?.
MnM Analyst
Jul, 2023
Key players in pharmaceutical contract manufacturing industry for North America region include:
- Pfizer
- Merck & Co., Inc.
- Boehringer Ingelheim
- AbbVie Inc.
- Roche
- Novartis
- GlaxoSmithKline
- Sanofi
- AstraZeneca
- Eli Lilly and Company among others
.James
Jul, 2023
Who are the top key players in the pharmaceutical contract manufacturing market in North America?.